Clinical trials

  • Yellow fever virus strain 17D-204 (live, attenuated) for Yellow fever
  • relacorilant (CORT-125134) for Endogenous Cushing syndrome
  • Mosunetuzumab for Chronic lymphocytic leukemia | Relapsed or refractory chronic lymphocytic leukemia
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS for Degenerative rotator cuff tendinopathy
  • DEXAMETHASONE PHOSPHATE for Primary immune thrombocytopenia
  • PLASMA for Congenital heart disease | Perioperative coagulation abnormalities
  • Olaparib for Glioblastoma
  • Tozinameran for COVID-19
  • NANOBODY AGAINST MACROPHAGE MANNOSE RECEPTOR, CONJUGATED WITH 1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID, LABELLED WITH GALLIUM GA-68 for Non-small cell lung cancer
  • POVETACICEPT for Immunoglobulin A nephropathy (IgAN)
  • NIVOLUMAB for Leptomeningeal disease
  • Cabozantinib for Metastatic clear cell renal cell carcinoma